title: [The intestinal microbiota: a boost for antitumor treatments].
abstract: Two new studies in mice, published in Science, show that the commensal bacteria populations in the gut play a key role in boosting responses to different antitumor regimens. These results argue for a rational use of antibiotics when managing infections in patients undergoing cancer therapies.
authors.affiliation: CR1 Inserm, C. Enric Gimenez 17-19, 08034 Barcelona, Espagne.
authors.forename: Adelaida
authors.initials: A
authors.lastname: Sarukhan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D064307:Microbiota / Q000187:drug effects / Q000502:physiology*; D009369:Neoplasms / Q000188:drug therapy / Q000382:microbiology; D059016:Tumor Microenvironment / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents